Literature DB >> 20308261

Surveillance of Australian workplace Based Respiratory Events (SABRE) in New South Wales.

K Hannaford-Turner1, D Elder, M R Sim, M J Abramson, A R Johnson, D H Yates.   

Abstract

BACKGROUND: The Surveillance of Australian workplace Based Respiratory Events (SABRE) New South Wales (NSW) scheme is a voluntary notification scheme established to determine the incidence of occupational lung diseases in NSW Australia. AIMS: Data presented in this paper summarize the last 7 years of reporting to SABRE (June 2001 to December 2008).
METHODS: Every 2 months, participating occupational physicians, respiratory physicians and general practitioners (accredited by the NSW WorkCover Authority) reported new cases of occupational lung disease seen in their practices. Data collected include gender, age, causal agent and the occupations and industries believed responsible. Estimated incidence was calculated for each disease.
RESULTS: Three thousand six hundred and fifty-four cases were notified to the scheme, consisting of 3856 diagnoses. Most of the cases were males (76%). Pleural plaques [1218 (28%)] were the most frequently reported condition, followed by mesothelioma [919 (24%)]. Silicosis [90 (2%)] and occupational asthma [OA; 89 (2%)] were the most frequently reported non-asbestos-related diseases. Estimated rates for mesothelioma, diffuse pleural thickening (DPT) and OA were 83, 83 and 5 cases per million employed males per year, respectively. Trades such as carpenters and electricians associated with the building industry, electricity supply and asbestos product manufacture were the most common occupations and industries reported.
CONCLUSIONS: Asbestos-related diseases are the most frequently reported conditions to SABRE NSW. The very low incidence of OA for NSW most likely reflects under-diagnosis as well as under-reporting. Occupational lung disease is still occurring in NSW despite current preventative strategies. The SABRE scheme currently provides the only available information in this area.

Entities:  

Mesh:

Year:  2010        PMID: 20308261     DOI: 10.1093/occmed/kqq011

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  7 in total

1.  Pleural mesothelioma surveillance: validity of cases from a tumour registry.

Authors:  France Labrèche; Bruce W Case; Gaston Ostiguy; Jean Chalaoui; Michel Camus; Jack Siemiatycki
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Feasibility of a provincial voluntary reporting system for work-related asthma in Ontario.

Authors:  Teresa To; Susan M Tarlo; Susan McLimont; Ted Haines; D Linn Holness; M Diane Lougheed; Gary M Liss; Lisa Cicutto
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

3.  Surveillance for occupational respiratory diseases in developing countries.

Authors:  Vinicius C Antao; Germania A Pinheiro
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

4.  Work-Related Asthma in Korea - Findings from the Korea Work-Related Asthma Surveillance (KOWAS) program, 2004-2009.

Authors:  Soon-Chan Kwon; Jaechul Song; Yong-Kyu Kim; Geoffrey M Calvert
Journal:  Allergy Asthma Immunol Res       Date:  2014-09-19       Impact factor: 5.764

5.  Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy.

Authors:  L Vimercati; D Cavone; A Caputi; M C Delfino; L De Maria; G M Ferri; G Serio
Journal:  BMC Res Notes       Date:  2019-09-30

6.  Awareness of Asbestos and Action Plans for Its Exposure can Help Lives Exposed to Asbestos.

Authors:  Hu-Jang Lee; Eun-Kee Park; Donald Wilson; Engin Tutkun; Chulho Oak
Journal:  Saf Health Work       Date:  2013-04-18

Review 7.  Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

Authors:  Ryan Hoy; Jonathan Burdon; Ling Chen; Susan Miles; Jennifer L Perret; Shivonne Prasad; Naghmeh Radhakrishna; Janet Rimmer; Malcolm R Sim; Deborah Yates; Graeme Zosky
Journal:  Respirology       Date:  2020-10-05       Impact factor: 6.424

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.